IQAI’s Sponsored Phase I Clinical Trial is Open
MILWAUKEE, WI / ACCESSWIRE / March 10, 2022 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) is pleased to announce that the sponsored...
Day: March 10, 2022
Emerging Technology Insider Releases a New TechTalks Video Interview Featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc.
Discussions Centered on the Expanding Partnership Between Pressure BioSciences & The Ohio State University, the Food Industry Consortium, and the...
Medisafe Expands Executive Leadership to Support Continued Growth
New chief strategy officer, chief financial officer to drive business partnershipsBOSTON, MA / ACCESSWIRE / March 10, 2022 / Medisafe,...
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate
Moderna's Omicron-specific bivalent booster candidate (mRNA-1273.214) combines Moderna's Omicron-specific booster candidate (mRNA-1273.529) and the Moderna COVID-19 vaccine (mRNA-1273)Moderna expects to...
Moderna to Host Third Annual Virtual Vaccines Day on March 24, 2022
CAMBRIDGE, MA / ACCESSWIRE / March 10, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Goodbody Health Confirms Strong 2021 Revenue Continuing into 2022
VANCOUVER, BC / ACCESSWIRE / March 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is...
CBD Life Sciences, Inc. (CBDL) Set to Present at ERRL Cup Cannabis Event
SCOTTSDALE, AZ / ACCESSWIRE / March 10, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary,...
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments
Completed concrete milestones in its strategy to become a leading psychedelic drug developer and specialty clinics operator. Developed clear drug...
Zealand Pharma convenes its Annual General Meeting 2022
Company Announcement – No. 8 / 2022 Zealand Pharma convenes its Annual General Meeting 2022 Copenhagen, 10 March, 2022 – Zealand Pharma...
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief...
Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
Company announcement – No. 7 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for...
HealthPoint Plus Launches V3.0 of Their Comprehensive Subscription-Based Telehealth Platform
The latest release adds expanded Primary Care support, Behavioral Health, and even Pet Telehealth to its already expansive Urgent Care...
Equip and Magellan Healthcare Collaborate to Offer Virtual Eating Disorder Treatment in California
Equip will offer in-network coverage for members and families that utilize Magellan across the stateSAN DIEGO, March 10, 2022 (GLOBE...
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery A Clinical Device Performance Study in Patients with...
Lumos Pharma to Participate in Upcoming Investor Conferences
AUSTIN, Texas, March 10, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare...
Delcath Systems to Present at the 34th Annual Roth Conference
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd.
$SPOM - SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd. Project -Shandong Provincial Third Hospital -...
Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA),...
Pure Extracts Receives Initial Purchase Order from New Brunswick
VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Enzo Biochem to Present at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum
NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company,...